Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
OBJECTIVE
To report control of intravitreal triamcinolone acetonide-induced elevated intraocular pressure (IOP) by vitrectomy-assisted corticosteroid removal.


METHODS
Interventional case series.


METHODS
Of the 26 eyes that had intravitreal injection of triamcinolone acetonide for various causes, 11 eyes (42.5%) developed elevated IOP. In nine eyes IOP was controlled by antiglaucoma medication. Two eyes of two patients developed uncontrolled IOP despite maximal antiglaucoma medication. These eyes underwent vitrectomy and removal of triamcinolone acetonide.


RESULTS
IOP returned to normal in 3 weeks and 1 week, respectively, after vitrectomy.


CONCLUSIONS
Elevated IOP associated with intravitreal injection of triamcinolone acetonide that is not controlled by maximal antiglaucoma medication can be effectively treated by vitrectomy-assisted removal of triamcinolone acetonide.
T. P. Agrawal Institute of Ophthalmology, Meerut, India. dr_shishir@vsnl.com <dr_shishir@vsnl.com>
Shishir
S
Agrawal
Jaya
J
Agrawal
Trilok Prakash
TP
Agrawal
D004322:Drainage / Q000379:methods; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure / Q000187:drug effects*; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000139:chemically induced / Q000601:surgery*; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014821:Vitrectomy / Q000379:methods*; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide